The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Changing causes of death post-epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) era in patients with advanced non-small cell lung cancer (NSCLC).
Wen Shuo Wu
No relevant relationships to disclose
Yuh-Min Chen
No relevant relationships to disclose
Chun-Ming Tsai
No relevant relationships to disclose
Jen-Fu Shih
No relevant relationships to disclose
Yu-Chin Lee
No relevant relationships to disclose
Reury-Perng Perng
No relevant relationships to disclose